ACRES Commercial Realty Corporation (ACR)       8.19  +0.03 (+0.37%)

8.19  +0.03 (+0.37%)

US00489Q1022 - REIT - After market: 8.19 0 (0%)


Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ACR. ACR was compared to 52 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. Both the profitability and financial health of ACR have multiple concerns. ACR has a correct valuation and a medium growth rate.




Profitability

Profitability Rating


ACR has a Return On Assets of 1.10%. This is comparable to the industry average of 1.62%.
The Piotroski-F score of ACR is 5.00. This is a neutral score and indicates average health and profitability for ACR.

ACR has a Return On Equity of 5.18%. This is below the industry average of 8.72%.
ACR's Profit Margin of 20.66% is worse than the rest of the industry. The industry average Profit Margin is 42.46%. 83% of the industry peers have a better Profit Margin.
VS Industry

ROA (1.1%) VS Industry: 43% outperformed.

-4.36
6.77

ROE (5.18%) VS Industry: 28% outperformed.

0.18
24.25

Profit Margin (20.66%) VS Industry: 17% outperformed.

-160.02
159.70

Valuation

Valuation Rating


With a Forward Price/Earnings Ratio of 4.94, the valuation of ACR can be described as cheap.
ACR's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the current price to the book value of ACR, it is valued rather cheaply. It is trading at 0.17 times its book value.

Compared to an average industry price book ratio of 0.74, ACR is valued rather cheaply. On top of this, ACR is cheaper than 100% of the companies listed in the same industry.
Compared to an average industry Enterprise Value to EBITDA ratio of 36.69, ACR is valued in line with its industry peers.
ACR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
VS Industry

Price/Book (0.17) VS Industry: 100% outperformed.

4.13
0.17

Enterprise Value/ EBITDA (34.94) VS Industry: 52% outperformed.

183.25
4.45

Growth

Growth Rating


Based on estimates for the next 5 years, ACR will show a very strong growth in Earnings Per Share. The EPS will grow by 260.24% on average per year.
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
ACR is expected to show quite a strong growth in Revenue. In the coming 5 years, the Revenue will grow by 17.31% yearly.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.

ACR shows a small growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 1.92% yearly.
ACR shows a small growth in Revenue. In the last year, the Revenue has grown by 9.91%.
The Revenue has been decreasing by -1.36% on average over the past 5 years.
ACR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -119.33%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS1.92% 10.02% -119.33% 2261.4% 492.69% 323.36% 260.24%
Revenue-1.36% -3.05% 9.91% 8.24% 17.41% 17.15% 17.31%

Health

Health Rating


The Piotroski-F score of ACR is 5.00. This is a neutral score and indicates average health and profitability for ACR.

Compared to an average industry Debt to Equity Ratio of 1.41, ACR is requires more financing than its industry peers. 85% of its industry peers have a better Debt to Equity Ratio.
VS Industry

Debt/Equity (3.67) VS Industry: 15% outperformed.

20.04
0.00

Dividend

Dividend Rating


ACR does not give a dividend.

ACR Daily chart

ACRES Commercial Realty Corporation8.19

NYSE:ACR (6/30/2022, 7:04:00 PM)+0.03 (+0.37%)

After market: 8.19 0 (0%)

Chartmill FA Rating
GICS Sector Financials
GICS IndustryGroup Diversified Financials
GICS Industry Mortgage Real Estate Investment Trusts (REITs)"
Earnings (Last) 05-05 2022-05-05/amc Earnings (Next) 08-02 2022-08-02
Ins Owners 2.5% Inst Owners 30.09%
Market Cap 74.53M Analysts 80
Valuation
PE N/A Fwd PE 4.94
PEG (NY) N/A PEG (5Y) N/A
P/S 0.67 P/B 0.17
EV/EBITDA 34.94
Profitability
ROA 1.1% ROE 5.18%
PM 20.66 Asset Turnover 0.05
Growth
EPS 1Y -119.33% EPS 3Y 10.02%
EPS 5Y 1.92% EPS growth Q2Q -2400%
EPS Next Y 2261.4% EPS Next 2Y 492.69%
EPS Next 3Y 323.36% EPS Next 5Y 260.24%
Revenue growth 1Y 9.91% Revenue growth 3Y -3.05%
Revenue growth 5Y -1.36% Revenue growth Q2Q -5.38%
Revenue Next Year 8.24% Revenue Next 2Y 17.41%
Revenue Next 3Y 17.15% Revenue Next 5Y 17.31%
Health
Current Ratio N/A Quick Ratio N/A
Altman-Z N/A F-Score 5
Debt/Equity 3.67
Dividend
Dividend Yield N/A Dividend Growth N/A
DP 72.37% Ex-Date N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA